DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Zeng Z, Sarbassov dD, Samudio IJ, Yee KW, Munsell MF, Ellen JC, Giles FJ, Sabatini DM, Andreeff M, Konopleva M.
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.
Blood 2007; 109: 3509-3512
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.